TEVA PHARMS USA INC FDA Approval ANDA 210142

ANDA 210142

TEVA PHARMS USA INC

FDA Drug Application

Application #210142

Documents

Letter2020-08-21

Application Sponsors

ANDA 210142TEVA PHARMS USA INC

Marketing Status

None (Tentative Approval)001
None (Tentative Approval)002

Application Products

001TABLET; ORAL2.5MG0APIXABANAPIXABAN

FDA Submissions

UNKNOWN; ORIG1TA2020-07-02STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

TEVA PHARMS USA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210142
            [companyName] => TEVA PHARMS USA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"APIXABAN","activeIngredients":"APIXABAN","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/02\/2020","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/210142Orig1s000TA_ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-07-02
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.